Depreciation Amortization - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Depreciation & Amortization Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Depreciation & Amortization
€871k
CAGR 3-Years
74%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Depreciation & Amortization
€27.1m
CAGR 3-Years
34%
CAGR 5-Years
30%
CAGR 10-Years
8%
Nanobiotix SA
PAR:NANO
Depreciation & Amortization
€1.5m
CAGR 3-Years
-5%
CAGR 5-Years
20%
CAGR 10-Years
21%
Innate Pharma SA
PAR:IPH
Depreciation & Amortization
€2.6m
CAGR 3-Years
-63%
CAGR 5-Years
-26%
CAGR 10-Years
5%
Genfit SA
NASDAQ:GNFT
Depreciation & Amortization
€1.7m
CAGR 3-Years
-23%
CAGR 5-Years
-2%
CAGR 10-Years
13%
Eurobio Scientific SA
PAR:ALERS
Depreciation & Amortization
€14.2m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is Maat Pharma SA's Depreciation & Amortization?
Depreciation & Amortization
871k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Depreciation & Amortization amounts to 871k EUR.

What is Maat Pharma SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
62%

Over the last year, the Depreciation & Amortization growth was 103%. The average annual Depreciation & Amortization growth rates for Maat Pharma SA have been 74% over the past three years , 62% over the past five years .

Back to Top